Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,868 | 12,020 | 8,948 | 10,764 | 8,680 |
| TOTAL | $11,552 | $13,013 | $9,709 | $11,813 | $10,083 |
| Non-Current Assets | |||||
| PPE Net | 34 | 44 | 55 | 65 | 75 |
| Other Non-Current Assets | 0 | 0 | 78 | 89 | 113 |
| TOTAL | $34 | $44 | $133 | $154 | $188 |
| Total Assets | $11,586 | $13,057 | $9,842 | $11,967 | $10,271 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 406 | 609 | 256 | 635 | 571 |
| Accrued Expenses | 1,250 | 1,499 | 1,575 | 1,438 | 2,457 |
| TOTAL | $1,656 | $2,108 | $1,850 | $2,101 | $3,077 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,656 | $2,108 | $1,850 | $2,101 | $3,077 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,973 | 5,973 | 5,906 | 5,906 | 5,906 |
| Common Shares | 60 | 59 | 59 | 59 | 30 |
| Retained earnings | -172,163 | -170,925 | -173,029 | -170,745 | -166,469 |
| TOTAL | $9,930 | $10,949 | $7,992 | $9,866 | $7,194 |
| Total Liabilities And Equity | $11,586 | $13,057 | $9,842 | $11,967 | $10,271 |